Funding for the global HIV response plunged in 2025, entirely due to a steep decline in U.S. support, according to reports ...
Among healthcare providers, 89% (n=16/18) reported a positive overall opinion of administering CAB LA for PrEP in their practice. Prescribers cited benefits of regular injection visits, including ...
Although new HIV infections and AIDS-related deaths are at their lowest levels in more than 30 years, the current HIV response is extremely fragile. Efforts to end AIDS as a public health threat by ...
The world’s richest man has passed a “slow death sentence” on an untold number of people with HIV by cutting US spending on ...
Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its ...
Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3 ...
Patients with HIV infection show increased prevalence of preserved ratio impaired spirometry (PRISm) and restrictive spirometry patterns (RSP), according to study findings publish ...
NACA calls for stronger domestic HIV funding in Nigeria to sustain the fight against the virus amidst declining international ...
We’ve all been there: a 2:00 a.m. “U Up?” text that wakes you out of a dead sleep. But before hitting send on that reply, Gilead Sciences suggests adding “U Up to Date?” on HIV testing to the ...
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the ...
Alcohol use remains one of the most prevalent and modifiable behavioral factors influencing HIV prevention, treatment, and long-term health. Across the HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results